WGS Q3 2025 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q3 2025 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$117M+51.9% YoY

Gross Profit

$85M72.4% margin

Operating Income

-$3M-2.8% margin

Net Income

-$8M-6.5% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+13.7%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$10M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$494M

Total Liabilities

$202M

Stockholders' Equity

$292M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$117M	$77M	+51.9%
Gross Profit	$85M	$48M	+76.7%
Operating Income	-$3M	-$8M	+58.2%
Net Income	-$8M	-$8M	+8.1%

Revenue Segments

Diagnostic Test

$114M49%

Diagnostic Test, Third Party Insurance

$95M41%

Diagnostic Test, Institutional Customers

$18M8%

Product and Service, Other

$3M1%

Diagnostic Test, Self Pay

$629,0000%